SEARCH

SEARCH BY CITATION

References

  • Alioglu, B., Avci, Z., Ozyurek, E. & Ozbek, N. (2007) Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia. Journal of Pediatiric Hematology Oncology, 29, 636639.
  • Boruchov, D.M., Gururangan, S., Driscoll, M.C. & Bussel, J.B. (2007) Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). Blood, 110, 35263531.
  • Cooper, N., Heddle, N.M., Haas, M., Reid, M.E., Lesser, M.L., Fleit, H.B., Woloski, B.M. & Bussel, J.B. (2004a) Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms. British Journal of Haematology, 124, 511518.
  • Cooper, N., Stasi, R., Cunningham-Rundles, S., Feuerstein, M.A., Leonard, J.P., Amadori, S. & Bussel, J.B. (2004b) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology, 125, 232239.
  • Kalpatthi, R. & Bussel, J.B. (2008) Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura. Current Opinion in Pediatrics, 20, 816.
  • Lazarus, A.H. & Crow, A.R. (2003) Mechanism of action of IVIG and anti-D in ITP. Transfusion and Apheresis Science, 28, 249255.
  • Meyer, O., Kiesewetter, H., Hermsen, M., Petriedes, P., Rose, M., Seibt, H. & Salama, A. (2006) Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Pediatric Blood & Cancer, 47, 721722.
  • Moser, A.M., Shalev, H. & Kapelushnik, J. (2002) Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura. Journal of Pediatric Hematology/Oncology, 19, 407411.
  • Newman, G.C., Novoa, M.V., Fodero, E.M., Lesser, M.L., Woloski, B.M. & Bussel, J.B. (2001) A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. British Journal of Haematology, 112, 10761078.
  • O’ Brien, S.H., Ritchey, A.K. & Smith, K.J. (2007) A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatric Blood & Cancer, 48, 173180.
  • Sandler, S.G. (2001) Intravenous Rh immune globulin for treating immune thrombocytopenic purpura. Current Opinion in Hematology, 8, 417420.
  • Sandler, S.G., Mallory, D., Trimble, J. & Nance, S.T. (1998) Intravenous anti-D treatment for immune thrombocytopenic purpura. Blood, 91, 26242625.
  • Scaradavou, A., Woo, B., Woloski, B.M., Cunningham-Rundles, S., Ettinger, L.J., Aledort, L.M. & Bussel, J.B. (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood, 89, 26892700.
  • Shad, A.T., Gonzalez, C.E. & Sandler, S.G. (2005) Treatment of immune thrombocytopenic purpura in children : current concepts. Paediatric Drugs, 7, 325336.
  • Shahgholi, E., Vosough, P., Sotoudeh, K., Arjomandi, K., Ansari, S., Salehi, S., Faranoush, M. & Ehsani, M.A. (2008) Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Indian Journal of Pediatrics, 75, 12311235.
  • Son, D.W., Jeon, I.S., Yang, S.W. & Cho, S.H. (2008) A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. Journal of Pediatric Hematology/Oncology, 30, 598601.
  • Tarantino, M.D. & Bolton-Maggs, P.H. (2007) Update on the management of immune thrombocytopenic purpura in children. Current Opinion in Hematology, 14, 526534.
  • Tarantino, M.D., Young, G., Bertolone, S.J., Kalinyak, K.A., Shafer, F.E., Kulkarni, R., Weber, L.C., Davis, M.L., Lynn, H. & Nugent, D.J. (2006) Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Journal of Pediatrics, 148, 489494.
  • Vesely, S., Buchanan, G.R., Cohen, A., Raskob, G. & George, J. (2000) Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. Journal of Pediatric Hematology/Oncology, 22, 5561.
  • Vesely, S.K., Buchanan, G.R., Adix, L., George, J.N., Cohen, A.R., Blanchette, V.S. & Kühne, T. (2003) Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. Journal of Pediatric Hematology/Oncology, 25, 130133.
  • Watts, R.G. (2004) Idiopathic thrombocytopenic purpura: a 10-year natural history study at the Childrens Hospital of Alabama. Clinical Pediatrics, 43, 691702.